Abstract
This overview provides a brief review of the 2023 American Heart Association, American College of Cardiology, American College of Clinical Pharmacy, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association guideline for the management of patients with chronic coronary disease. Clinical recommendations with a focus on a team-based approach, lifestyle modification, risk stratification, diagnostic testing, and pharmacologic and nonpharmacologic management are discussed.